NEW YORK, July 20 /PRNewswire/ — Susquehanna
Financial Group, LLLP (SFG), the institutional broker-dealer member
of the Susquehanna International Group of Companies (SIG),
announced today that Gary Nachman
has joined the firm as the Senior Analyst covering the Specialty
Pharmaceuticals sector. Mr. Nachman, whose coverage will include
names such as Allergan, Cephalon, Forest
Labs, King Pharmaceuticals, Shire Pharmaceuticals and Warner Chilcott, will be based out of
SFG’s New York office.
“Gary is an exciting addition to SFG’s growing Healthcare
research team – which consists of A.J. Rice (Healthcare Facilities and
Services), Chris Rigg (Managed Care)
and David Turkaly (Medical Supplies
and Devices),” said Mike Towey,
SFG’s Director of Research. “The addition of Gary brings us to 23
senior fundamental analyst teams in six major industry sectors
(Financial, Consumer, Healthcare, Energy, Industrials, and TMT).
Gary’s coverage of the Specialty Pharmaceuticals sector is the
perfect complement to our healthcare team and will further leverage
our healthcare trading efforts, led by Michael Karmiol.”
“Gary is a premier analyst in the sector and we are excited to
have him join our formidable Healthcare vertical. Gary’s research
is thoughtful and differentiated and his industry experience was
very appealing to us,” stated Cory
Carlesimo, SFG’s Head of Equities. “We think that experience
is additive to the investment process for our clients and is why a
significant number of the 75+ hires we have made year to date have
had e
‘/>”/>
